| Name | methyl 4-(benzylamino)-2-methoxy-5-nitrobenzoate |
|---|
| Molecular Formula | C16H16N2O5 |
|---|---|
| Molecular Weight | 316.30900 |
| Exact Mass | 316.10600 |
| PSA | 93.38000 |
| LogP | 3.59830 |
|
~%
89722-54-3 |
| Literature: Glenmark Pharmaceuticals S.A. Patent: US2012/108583 A1, 2012 ; Location in patent: Page/Page column 22 ; US 20120108583 A1 |
|
~%
89722-54-3 |
| Literature: Glenmark Pharmaceuticals S.A. Patent: US2012/108583 A1, 2012 ; US 20120108583 A1 |
|
~%
89722-54-3 |
| Literature: Glenmark Pharmaceuticals S.A. Patent: US2012/108583 A1, 2012 ; US 20120108583 A1 |
|
~%
89722-54-3 |
| Literature: Glenmark Pharmaceuticals S.A. Patent: US2012/108583 A1, 2012 ; US 20120108583 A1 |